Investing
Sales of short-term available-for-sale investments
Gilead Sciences Sales of short-term available-for-sale investments increased by 641.2% to $2.52B in Q1 2026 compared to the prior quarter. Over 3 years (FY 2021 to FY 2025), Sales of short-term available-for-sale investments shows an upward trend with a 5.4% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
First reportedQ1 2019
Last reportedQ1 2026May 7, 2026
Metric ID:
adi_sales_of_short_term_investmentsHistorical Data
17 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $191.00M | $255.00M | $224.00M | $119.00M | $204.00M | $47.00M | $42.00M | $167.00M | $150.00M | $95.00M | $98.00M | $2.27B | $0.00 | $295.00M | $219.00M | $340.00M | $2.52B |
| QoQ Change | — | +33.5% | -12.2% | -46.9% | +71.4% | -77.0% | -10.6% | +297.6% | -10.2% | -36.7% | +3.2% | >999% | -100.0% | — | -25.8% | +55.3% | +641.2% |
| YoY Change | — | — | — | — | +6.8% | -81.6% | -81.3% | +40.3% | -26.5% | +102.1% | +133.3% | >999% | -100.0% | — | — | — | — |
Range$0.00 – $2.52B
CAGR+90.6%
Avg YoY Growth+138.8%
Median YoY Growth+6.8%
Current Streak2 quarters growth
Sales of short-term available-for-sale investments at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's sales of short-term available-for-sale investments?
- Gilead Sciences (GILD) reported sales of short-term available-for-sale investments of $2.52B in Q1 2026.
- What is the long-term trend for Gilead Sciences's sales of short-term available-for-sale investments?
- Over 3 years (2021 to 2025), Gilead Sciences's sales of short-term available-for-sale investments has grown at a 5.4% compound annual growth rate (CAGR), from $730.00M to $854.00M.